These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28880900)

  • 1. Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    Maulucci G; Cordelli E; Rizzi A; De Leva F; Papi M; Ciasca G; Samengo D; Pani G; Pitocco D; Soda P; Ghirlanda G; Iannello G; De Spirito M
    PLoS One; 2017; 12(9):e0184109. PubMed ID: 28880900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane fluidity as a marker of diabetic retinopathy in type 1 diabetes mellitus.
    Bianchetti G; Viti L; Scupola A; Di Leo M; Tartaglione L; Flex A; De Spirito M; Pitocco D; Maulucci G
    Eur J Clin Invest; 2021 May; 51(5):e13455. PubMed ID: 33210748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
    Watala C; Winocour PD
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):513-9. PubMed ID: 1457612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cells membrane micropolarity as a novel diagnostic indicator of type 1 and type 2 diabetes.
    Bianchetti G; Di Giacinto F; Pitocco D; Rizzi A; Rizzo GE; De Leva F; Flex A; di Stasio E; Ciasca G; De Spirito M; Maulucci G
    Anal Chim Acta X; 2019 Nov; 3():100030. PubMed ID: 33117983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decision support system for type 1 diabetes mellitus diagnostics based on dual channel analysis of red blood cell membrane fluidity.
    Cordelli E; Maulucci G; De Spirito M; Rizzi A; Pitocco D; Soda P
    Comput Methods Programs Biomed; 2018 Aug; 162():263-271. PubMed ID: 29903493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes.
    Watała C; Zawodniak M; Bryszewska M; Nowak S
    Ann Clin Res; 1985; 17(6):327-30. PubMed ID: 4096489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process.
    Mazzanti L; Faloia E; Rabini RA; Staffolani R; Kantar A; Fiorini R; Swoboda B; De Pirro R; Bertoli E
    Clin Biochem; 1992 Feb; 25(1):41-6. PubMed ID: 1312917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Na+/K(+)-ATPase activity and fluidity of erythrocyte membranes from relatives of insulin dependent diabetic patients.
    Rabini RA; Galassi R; Staffolani R; Vasta M; Fumelli P; Mazzanti L
    Diabetes Res; 1993; 22(1):33-40. PubMed ID: 8200183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial Reorganization of Liquid Crystalline Domains of Red Blood Cells in Type 2 Diabetic Patients with Peripheral Artery Disease.
    Bianchetti G; Rizzo GE; Serantoni C; Abeltino A; Rizzi A; Tartaglione L; Caputo S; Flex A; De Spirito M; Pitocco D; Maulucci G
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients.
    Rabini RA; Fumelli P; Galassi R; Dousset N; Taus M; Ferretti G; Mazzanti L; Curatola G; Solera ML; Valdiguié P
    Metabolism; 1994 Dec; 43(12):1470-4. PubMed ID: 7990698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes.
    Bryszewska M; Watała C; Torzecka W
    Br J Haematol; 1986 Jan; 62(1):111-6. PubMed ID: 3942692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactions of modified lipoproteins with human erythrocyte membranes.
    Jóźwiak Z; Pałecz D; Bartosz G
    Biochem Mol Biol Int; 1994 Feb; 32(2):259-67. PubMed ID: 8019431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a relationship between protein glycation and red blood cell membrane fluidity.
    Birlouez-Aragon I; Scalbert-Menanteau P; Morawiec M; Shafiezadeh M
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1107-13. PubMed ID: 2390079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluidity gradient of erythrocyte membranes in diabetics: the effect of resorcylidene aminoguanidine.
    Waczulíková I; Sikurová L; Cársky J
    Bioelectrochemistry; 2002 Jan; 55(1-2):53-5. PubMed ID: 11786339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus.
    Manjunatha S; Distelmaier K; Dasari S; Carter RE; Kudva YC; Nair KS
    Metabolism; 2016 Sep; 65(9):1421-31. PubMed ID: 27506748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects.
    Winocour PD; Watala C; Kinglough-Rathbone RL
    Thromb Haemost; 1992 May; 67(5):567-71. PubMed ID: 1519216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte fluidity in patients with hyperlipidemia during statins therapy].
    Broncel M; Chojnowska-Jezierska J; Koter-Michalak M; Franiak I
    Pol Arch Med Wewn; 2005 Jun; 113(6):531-7. PubMed ID: 16454441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional antioxidants, red cell membrane fluidity and blood viscosity in type 1 (insulin dependent) diabetes mellitus.
    Osterode W; Holler C; Ulberth F
    Diabet Med; 1996 Dec; 13(12):1044-50. PubMed ID: 8973886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
    Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
    Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.